John Bennetts
Addiction Medicine · Monterey, CANPI 1477666345
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,408 of the $5,419 with a category attached, or 81.3%. It is spread thinly across 32 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,185 and has fallen 54.1% since, to $1,004 in 2022. Among addiction medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AbbVie$1K
- GSK$788
- Sunovion Pharmaceuticals Inc.$385
- Mylan Specialty L.p.$303
- Abbott$273
- plus $1K from 26 others
What the payments were for
- Speaking & faculty fees$1,00018%
- Food & beverage$4,40881%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 9 | $1,174 |
| AbbVie(2 entities) | 77 | $1,046 |
| GSK | 41 | $788 |
| Sunovion Pharmaceuticals Inc. | 19 | $385 |
| Mylan Specialty L.p. | 12 | $303 |
| Abbott | 18 | $273 |
| Pfizer | 17 | $215 |
| Boehringer Ingelheim | 6 | $160 |
| Vertos Medical, Inc. | 1 | $129 |
| Amgen | 5 | $118 |
| Redhill Biopharma Inc. | 5 | $95 |
| Indivior Inc. | 4 | $90 |
| Merck | 4 | $86 |
| AstraZeneca | 4 | $67 |
| Novo Nordisk | 3 | $57 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Boston Scientific | 1 | $43 |
| Vivus LLC | 2 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Eisai Inc. | 1 | $23 |
| Radius Health, Inc. | 1 | $22 |
| Lupin Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $17 |
| Biodelivery Sciences International, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CYMBALTA$1,000
- mild Device Kit$129
How this compares
$5,419 in reported general payments places this provider in the 90th percentile of 190 addiction medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $186 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Monterey
- Tipu KhanVentura$262K
- Anthony AlbaneseMather$135K
- Matthew TorringtonCulver City$77K
- Kenneth StarrArroyo Grande$64K
- Drew PinskySouth Pasadena$60K
- Mark HonzelBeverly Hills$27K
- Bryan HylerVista$17K
- Abraham MalkinLos Angeles$12K
- Jonathan ReitmanBeverly Hills$11K
- Caleb LuskSan Pedro$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.